Haemostatic agents*
| Group of haemostatic agents (ATC code) | Haemostatic agents (ATC code) |
|---|---|
| Antifibrinolytics (B02AA) | Tranexamic acid (B02AA02) |
| Vitamin K (B02BA) | Phytomenadione (B02BA01) |
| Fibrinogen (B02BB) | Fibrinogen, human (B02BB01) |
| Coagulation factor concentrates (B02BD) | Prothrombin complex concentrate (B02BD01) |
| Activated prothrombin complex concentrate (B02BD03) | |
| Eptacog alfa (activated) (B02BD08) | |
| Antidotes (V03AB) | Protamine (V03AB14) |
*New haemostatic agents, including specific antagonist of Xa inhibitors or dabigatran, which may enter the market during our study, will also be included in the study when they are introduced in the hospital.